LONDON BROKER RATINGS: Deutsche Bank Research cuts Eurowag to 'hold'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
Price | 382.00p on 03-10-2025 | at 18:15:06
---|---|
Change | 0.00p 0% |
Buy | 383.00p |
Sell | 381.00p |
Last Trade: | Buy 3,667.00 at 382.00p |
Day's Volume: | 10,864 |
Last Close: | 382.00p |
Open: | 382.00p |
ISIN: | GB00BRKD9Z53 |
Day's Range | 381.00p - 383.00p |
52wk Range: | 320.00p - 654.00p |
Market Capitalisation: | £223.00m |
VWAP: | 381.71231p |
Shares in Issue: | 58.38m |
MJGleeson (GLE) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 3,667 | 382.00p | Suspected BUY Trade |
16:35:12 - 03-Oct-25 |
Buy* | 2 | 383.00p | SI Trade |
16:29:36 - 03-Oct-25 |
Buy* | 34 | 383.00p | Automatic Execution |
16:29:35 - 03-Oct-25 |
Buy* | 128 | 382.00p | Automatic Execution |
16:29:07 - 03-Oct-25 |
Sell* | 317 | 381.00p | Automatic Execution |
16:28:58 - 03-Oct-25 |
Sell* | 142 | 382.00p | Automatic Execution |
16:28:58 - 03-Oct-25 |
Sell* | 248 | 382.00p | Automatic Execution |
16:28:58 - 03-Oct-25 |
Sell* | 47 | 382.00p | Automatic Execution |
16:22:15 - 03-Oct-25 |
Sell* | 1,009 | 383.5202p | Ordinary |
16:03:13 - 03-Oct-25 |
Sell* | 22 | 380.00p | SI Trade |
15:05:11 - 03-Oct-25 |
MJGleeson (GLE) Regulatory News |
||
Date | Source | Headline |
---|---|---|
22nd Sep 2025 5:01 pm | RNS | REPLACEMENT: Director/PDMR Shareholding |
18th Sep 2025 7:00 am | RNS-R | Presentation on Engage Investor Platform |
17th Sep 2025 4:23 pm | RNS | Director/PDMR Shareholding |
16th Sep 2025 7:00 am | RNS | Audited results for the year ended 30 June 2025 |
9th Sep 2025 10:45 am | RNS | Director/PDMR Shareholding |
13th Aug 2025 7:00 am | RNS | Notice of Full-Year Results and Presentation |
7th Aug 2025 3:05 pm | RNS | Director/PDMR Shareholding |
10th Jul 2025 4:17 pm | RNS | Director/PDMR Shareholding |
9th Jul 2025 1:05 pm | RNS | Holding(s) in Company |
8th Jul 2025 4:00 pm | RNS | Director/PDMR Shareholding |